Wisan, Baby Girl .
HRN: 27-78-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/20/2025
09/27/2025
IV
40mg
Q24
Sepsis Neonatorum
Waiting Final Action
Indication: Culture-directed Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes